CraniUS Therapeutics
PrivateLast Round
Series B
Jan 28, 2026
Total Funding Raised
$40.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CraniUS Therapeutics is a neurotechnology company developing a fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CraniUS Therapeutics Comparables
Compare CraniUS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theracle | 85% | |
| Cognos Therapeutics Inc | 84% | |
| Precision NeuroMed | 82% | |
CraniUS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2026 | ||||
| Grant | Jun 26, 2024 | ||||
| Series A | Sep 27, 2022 |
CraniUS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maryland Department of Commerce | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 98% MoM, reaching 1.6K.
- Jan 28, 2026
$20M round completed.
CraniUS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |